Vitacost.com reports financial results for the third quarter and nine-month periods ended September 30, 2009

NewsGuard 100/100 Score

Vitacost.com, Inc. (NASDAQ: VITC), a leading online retailer and direct marketer of health and wellness products, today reported financial results for the third quarter and nine-month periods ended September 30, 2009.

Third Quarter of 2009 Operating Highlights Include:

  • Net Sales increased 32% to $48.4 million, compared to $36.7 million for the third quarter of 2008
  • Active customer base (1) expanded to over 1 million customers during the quarter
  • Gross Profit Margin Increased 720 basis points to 31.2% from the prior year period
  • Pro Forma Operating Margins improved to 8.7% compared to 0.1% in the prior year period
  • Adjusted EBITDA improved to $5.1 million, a 465% increase
  • Pro Forma Net Income increased to $3.1 million or $0.13 Per Fully Diluted Share, calculated on weighted average of 23.7 million shares outstanding, excluding $10.9 million of a one-time IPO related non-cash compensation

Three Month Results

For the third quarter, net sales increased 32% to $48.4 million from net sales of $36.7 million for the third quarter of the prior year. Both of the Company’s primary sales categories, propriety and third party products, contributed to this strong year-over-year increase by generating record third quarter results.

Gross profit for the third quarter increased 71% to $15.1 million, compared to $8.8 million in the third quarter of the prior year. The Company's gross profit margin increased to 31.2% in the third quarter versus 24.0% in the third quarter of the prior year. Overall, gross profit margins improved by 720 basis points primarily due to transitioning manufacturing of proprietary capsules and tablets from third-party manufacturers to in-house manufacturing, increased purchasing power due to higher sales volume of third-party product, and the raw materials used for manufacturing our proprietary products.

Pro forma operating income for the third quarter was $4.2 million compared to $0.1 million in the same period a year ago. The Company’s pro forma operating margin expanded to 8.7% from 0.0% for the same period last year. This improvement was due to strong net sales growth, leverage of sales and marketing expense, and the strength of the Company’s proven business model. The company's GAAP operating loss, which includes a $10.9 million one-time non-cash stock-based compensation expense in connection with the recent initial public offering, was $(6.7) million in the third quarter of 2009 compared with $0.1 million in the third quarter of 2008.

Adjusted EBITDA (earnings before interest, taxes, depreciation, amortization and related non-cash compensation expense) for the third quarter of 2009 was $5.1 million, compared to $0.9 million in the previous year.

Pro Forma net income for the third quarter of 2009 was $3.1 million, or $0.13 per diluted share calculated on a weighted average fully diluted share count of 23.7 million shares, versus a net loss of $(0.1) million, or $(0.01) per diluted share, for the comparable period last year. The Company's GAAP net loss, which includes the $10.9 million one-time non-cash stock-based compensation expense in connection with the recent initial public offering, was $(3.8) million in the third quarter of 2009 or $(0.17) per diluted share, compared with a net loss of $(0.1) million or $(0.01) per diluted share in the third quarter of 2008.

“We are extremely pleased with our top-line growth, operating and manufacturing improvements, and strong operating cash flow for the third quarter and first nine months of this year. Third quarter net sales increased in our two primary net sales sources — third party products and propriety products — underscoring our expanding product offering as well as customer growth. Notably, both our propriety and third party sales achieved record results, driven by many factors including our superior customer value, product selection, and experience,” said Ira Kerker, Vitacost’s Chief Executive Officer. “Our business is well positioned for long-term profitable growth and margin expansion even as we continue to invest in our information technology and marketing strategies. Customer acquisition cost was $12.68 for the quarter and by offering the best value, superior customer service and timely and accurate delivery of leading products we expect our active customer base of over 1 million customers to continue growing for many years to come.”

Nine Month Results

For the nine months ended September 30, 2009, net sales increased 34% to $141.5 million compared to $105.4 million in the same period last year.

Pro Forma operating income for the nine months ended September 30, 2009 improved to $16.1 million compared to $1.1 million in the same period last year. GAAP operating income, which includes the $10.9 million one-time non-cash stock-based compensation expense in connection with the recent initial public offering, was $5.2 million compared to $1.1 million in the same period last year.

Operating cash flow was $14.3 million for the nine months compared to a $(0.9) million for the previous year nine-months and Adjusted EBITDA for the nine-months was $19.0 million compared to $3.4 million in the same period last year.

Free cash flow was $8.2 million for the nine months ended September 30, 2009 compared to $(5.5) million last year. (Free cash flow is calculated using net cash provided by operating activities less capital expenditures for property, plant and equipment).

Pro forma net income was $10.3 million, or $0.44 per diluted share, compared to net income of $0.6 million, or $0.02 per diluted share, in the same period last year. The Company's GAAP net income, which includes the $10.9 million one-time non-cash stock-based compensation expense in connection with the recent initial public offering, was $3.3 million or $0.14 per fully diluted share for the first nine months of 2009 compared with net income of $0.6 million or $0.02 per fully diluted share for the first nine months of 2008.

Successful Initial Public Offering

On September 24, 2009, the Company completed an initial public offering of its common stock at $12.00 per share and raised $132 million. The Company received approximately $47.1 million in net proceeds. The net proceeds to the Company from this offering are being used to repay existing indebtedness, approximately $20 million to fund capital expenditures such as purchasing fulfillment and manufacturing equipment and retrofitting and expanding the manufacturing and distribution facilities; and the balance for working capital, reducing notes payables and general corporate purposes.

Richard Smith, Chief Financial Officer, commented, “Our recent initial public offering combined with over $14.3 million of operating cash flow for the first nine months of this year enables us to complete our manufacturing expansion and continued investments in technological infrastructure. Our growing active customer base of over 1 million customers and the strength of our balance sheet have us well positioned for many years of future growth.”

Balance Sheet

The Company ended the third quarter of 2009 with cash and cash equivalents of $48.4 million as of September 30, 2009. As of September 30, 2009, the Company had $7.7 million of notes payable.

Outlook

For the fourth quarter of 2009, the Company anticipates revenue of $48.0 to 49.0 million. Earnings per diluted share for the fourth quarter are expected to be in the range of $0.07 to $0.08. Weighted average shares for diluted EPS in the fourth quarter of 2009 are estimated to be approximately 29.5 million shares, compared to 23.7 million shares at the end of the third quarter 2009, primarily resulting from the issuance of shares in the Company's IPO.

For the full year ending December 31, 2009, the Company expects revenue of $189.5 to $190.5 million and pro forma earnings per diluted share of $0.50 to $0.51, excluding the non-cash stock-based compensation expense in connection with the recent IPO outlined above. Weighted average shares used to calculate diluted earnings per share for the full year ending December 31, 2009 are estimated to be approximately 25.1 million shares.

Source: Vitacost.com, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
LungVax vaccine uses DNA technology to prevent lung cancer